K192926 is an FDA 510(k) clearance for the RxSight Insertion Device. Classified as Folders And Injectors, Intraocular Lens (iol) (product code MSS), Class I - General Controls.
Submitted by Rxsight, Inc. (Aliso Viejo, US). The FDA issued a Cleared decision on January 17, 2020 after a review of 93 days - within the typical 510(k) review window.
This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4300 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.
View all Rxsight, Inc. devices